CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 15 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Earnings Release: CYCLO THERAPEUTICS ($CYTH) is set to announce its quarterly earnings on March 17th, with analysts predicting revenue of $328,440 and a loss of -$0.17 per share.
Investor Activity: Recent data shows that 6 institutional investors have increased their holdings in CYCLO THERAPEUTICS, while 9 have reduced their positions in the last quarter.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
